A common variant association study in ethnic Saudi Arabs reveals novel susceptibility loci for hypertriglyceridemia

Hypertriglyceridemia (hTG) is a lipid disorder, resulting from an elevation in triglyceride levels, with a strong genetic component. It constitutes a significant risk factor for coronary artery disease (CAD), a leading cause of death worldwide. In this study, we performed a common variant association study for hTG in ethnic Saudi Arabs. We genotyped 5501 individuals in a two‐phase experiment using Affymetrix Axiom® Genome‐Wide CEU 1 Array (Affymetrix, Santa Cruz, CA) that contains a total of 587,352 single nucleotide polymorphisms (SNPs). The lead variant was the rs1558861 [1.99 (1.73–2.30); p = 7.37 × 10−22], residing on chromosome (chr) 11 at the apolipoprotein A‐I/A‐5 (APOA1/APOA5) locus. The rs780094 [1.34 (1.21–1.49); p = 8.57 × 10−8] on chr 2 at the glucokinase regulatory protein (GCKR) locus was similarly significantly associated, while the rs10911205 [1.29 (1.16–1.44); p = 3.52 × 10−6] on chr1 at the laminin subunit gamma‐1 (LAMC1) locus showed suggestive association with disease. Furthermore, the rs17145738 [0.68 (0.60–0.77); p = 6.69 × 10−9] on chr7 at the carbohydrate‐responsive element‐binding protein‐encoding (MLXIPL) gene locus displayed significant protective characteristics, while another variant rs6982502 [0.76 (0.68–0.84); p = 5.31 × 10−7] on chr8 showed similar but weaker properties. These findings were replicated in 317 cases vs 1415 controls from the same ethnic Arab population. Our study identified several variants across the human genome that are associated with hTG in ethnic Arabs.

[1]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[2]  Ying Liu,et al.  FaST linear mixed models for genome-wide association studies , 2011, Nature Methods.

[3]  C. Shoulders,et al.  Evidence of a Polygenic Origin of Extreme High-Density Lipoprotein Cholesterol Levels , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[4]  J. Liepnieks,et al.  Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. , 1988, Biochemical and biophysical research communications.

[5]  Hae-Young Lee,et al.  Aging and arterial stiffness. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[6]  R. Iqbal,et al.  Genetic association of lipid metabolism related SNPs with myocardial infarction in the Pakistani population , 2014, Molecular Biology Reports.

[7]  A. Ghasemi,et al.  C771G (His241Gln) Polymorphism of MLXIPL Gene, TG levels and coronary artery disease: A case control study , 2014, Anatolian journal of cardiology.

[8]  W.‐C. Lee Testing the Genetic Relation Between Two Individuals Using a Panel of Frequency‐unknown Single Nucleotide Polymorphisms , 2003, Annals of human genetics.

[9]  S. Eyheramendy,et al.  APOA5 Q97X Mutation Identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family , 2012, BMC Medical Genetics.

[10]  V. Salomaa,et al.  Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia , 2010, Nature Genetics.

[11]  N. Timpson,et al.  Association of Common Genetic Variants with Lipid Traits in the Indian Population , 2014, PloS one.

[12]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[13]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[14]  S. Yusuf,et al.  Polygenic determinants of severe hypertriglyceridemia. , 2008, Human molecular genetics.

[15]  Zhiming Huang,et al.  A novel lipoprotein lipase gene missense mutation in Chinese patients with severe hypertriglyceridemia and pancreatitis , 2014, Lipids in Health and Disease.

[16]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[17]  Xiaojun Tang,et al.  Association study of genetic variants at newly identified lipid gene TRIB1 with coronary heart disease in Chinese Han population , 2015, Lipids in Health and Disease.

[18]  S. Humphries,et al.  The genetic architecture of the familial hyperlipidaemia syndromes: rare mutations and common variants in multiple genes , 2014, Current opinion in lipidology.

[19]  J. Lupski,et al.  Whole-Exome Sequencing Reveals GPIHBP1 Mutations in Infantile Colitis With Severe Hypertriglyceridemia , 2014, Journal of pediatric gastroenterology and nutrition.

[20]  G. Cui,et al.  A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency. , 2014, Journal of the American College of Cardiology.

[21]  S. Yusuf,et al.  A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia , 2009, Human molecular genetics.

[22]  Päivi Pajukanta,et al.  Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci , 2013, Journal of Medical Genetics.

[23]  R. Hegele,et al.  Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia , 2012, Journal of internal medicine.

[24]  P. Pajukanta,et al.  Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia , 2007, Nature Genetics.

[25]  R. Hegele,et al.  Genetic bases of hypertriglyceridemic phenotypes , 2011, Current opinion in lipidology.

[26]  F. Azizi,et al.  Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study , 2015, British Journal of Nutrition.

[27]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[28]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[29]  E. Boerwinkle,et al.  Association of rs780094 in GCKR with Metabolic Traits and Incident Diabetes and Cardiovascular Disease: The ARIC Study , 2010, PloS one.

[30]  C. Bauters,et al.  [Pathophysiology of coronary artery disease]. , 2008, La Revue du praticien.

[31]  P. Hawkins,et al.  Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Hokanson,et al.  Lipoprotein lipase gene sequencing and plasma lipid profile[S] , 2014, Journal of Lipid Research.

[33]  Tanya M. Teslovich,et al.  Common variants associated with plasma triglycerides and risk for coronary artery disease , 2013, Nature Genetics.

[34]  Association of glucokinase regulatory protein polymorphism with type 2 diabetes and fasting plasma glucose: a meta-analysis , 2013, Molecular Biology Reports.

[35]  S. Kathiresan,et al.  Genetic determinants of plasma triglycerides , 2011, Journal of Lipid Research.

[36]  K. Kohara,et al.  The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population , 2010, Journal of Human Genetics.

[37]  R. Gregg,et al.  A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. , 1990, Genomics.

[38]  J. Klovins,et al.  Association between CETP, MLXIPL, and TOMM40 polymorphisms and serum lipid levels in a Latvian population , 2014, Meta gene.

[39]  S. Humphries,et al.  Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations , 2014, Journal of Medical Genetics.

[40]  T. Ando,et al.  Association of the GCKR rs780094 polymorphism with metabolic traits including carotid intima-media thickness in Japanese community-dwelling men, but not in women , 2014, Clinical chemistry and laboratory medicine.

[41]  G. Can,et al.  Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[42]  Yun Liu,et al.  Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population[S] , 2011, Journal of Lipid Research.

[43]  E. Lefai,et al.  An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. , 2014, American journal of human genetics.

[44]  R. Mateo-Gallego,et al.  Common Genetic Variants Contribute to Primary Hypertriglyceridemia Without Differences Between Familial Combined Hyperlipidemia and Isolated Hypertriglyceridemia , 2014, Circulation. Cardiovascular genetics.

[45]  D. Meyre,et al.  APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children , 2017, Pediatric obesity.

[46]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[47]  Association of the MLXIPL/TBL2 rs17145738 SNP and serum lipid levels in the Guangxi Mulao and Han populations , 2013, Lipids in Health and Disease.

[48]  Y. Tsai,et al.  Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster , 2013, Nutrition & Diabetes.

[49]  L. Wilkins Functional Analysis of the TRIB1 Associated Locus Linked to Plasma Triglycerides and Coronary Artery Disease , 2016, Journal of the American Heart Association.

[50]  R. Fresa,et al.  Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[51]  D. Booth,et al.  Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. , 1994, The Quarterly journal of medicine.

[52]  Inês Barroso,et al.  Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[53]  T. Nielsen,et al.  The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes , 2007, Diabetologia.

[54]  A. Hofman,et al.  Low-density lipoprotein receptor mutations generate synthetic genome-wide associations , 2012, European Journal of Human Genetics.

[55]  M. Taskinen,et al.  Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. , 2009, The Journal of clinical endocrinology and metabolism.

[56]  F. Hu,et al.  Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population , 2009, Diabetologia.

[57]  P. D. de Bakker,et al.  Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease , 2014, PloS one.

[58]  D. Heckerman,et al.  Further Improvements to Linear Mixed Models for Genome-Wide Association Studies , 2014, Scientific Reports.

[59]  J. Hubacek,et al.  Association of metabolic and genetic factors with cholesterol esterification rate in HDL plasma and atherogenic index of plasma in a 40 years old Slovak population. , 2011, Physiological research.

[60]  B. Melegh,et al.  Triglyceride level modifying functional variants of GALTN2 and MLXIPL in patients with ischaemic stroke , 2010, European journal of neurology.